Clinical Effects of Zilucoplan in Patients With Generalized Myasthenia Gravis

This randomized clinical trial evaluates the clinical effects of zilucoplan, a subcutaneously self-administered macrocyclic peptide inhibitor of complement component 5, in a broad population of patients with moderate to severe generalized myasthenia gravis.
Source: JAMA Neurology - Category: Neurology Source Type: research